Your browser doesn't support javascript.
loading
Role of sex hormones in modulating myocardial perfusion and coronary flow reserve.
Haider, Ahmed; Bengs, Susan; Portmann, Angela; Rossi, Alexia; Ahmed, Hazem; Etter, Dominik; Warnock, Geoffrey I; Mikail, Nidaa; Grämer, Muriel; Meisel, Alexander; Gisler, Livio; Jie, Caitlin; Keller, Claudia; Kozerke, Sebastian; Weber, Bruno; Schibli, Roger; Mu, Linjing; Kaufmann, Philipp A; Regitz-Zagrosek, Vera; Ametamey, Simon M; Gebhard, Catherine.
Affiliation
  • Haider A; Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Bengs S; Center for Molecular Cardiology, University of Zurich, CH-8952, Schlieren, Switzerland.
  • Portmann A; Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Rossi A; Center for Molecular Cardiology, University of Zurich, CH-8952, Schlieren, Switzerland.
  • Ahmed H; Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Etter D; Center for Molecular Cardiology, University of Zurich, CH-8952, Schlieren, Switzerland.
  • Warnock GI; Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Mikail N; Center for Molecular Cardiology, University of Zurich, CH-8952, Schlieren, Switzerland.
  • Grämer M; Institute of Pharmaceutical Sciences, ETH Zurich, CH-8093, Zurich, Switzerland.
  • Meisel A; Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Gisler L; Center for Molecular Cardiology, University of Zurich, CH-8952, Schlieren, Switzerland.
  • Jie C; Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Keller C; Center for Molecular Cardiology, University of Zurich, CH-8952, Schlieren, Switzerland.
  • Kozerke S; Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Weber B; Center for Molecular Cardiology, University of Zurich, CH-8952, Schlieren, Switzerland.
  • Schibli R; Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Mu L; Center for Molecular Cardiology, University of Zurich, CH-8952, Schlieren, Switzerland.
  • Kaufmann PA; Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Regitz-Zagrosek V; Center for Molecular Cardiology, University of Zurich, CH-8952, Schlieren, Switzerland.
  • Ametamey SM; Institute of Pharmaceutical Sciences, ETH Zurich, CH-8093, Zurich, Switzerland.
  • Gebhard C; Institute of Pharmaceutical Sciences, ETH Zurich, CH-8093, Zurich, Switzerland.
Eur J Nucl Med Mol Imaging ; 49(7): 2209-2218, 2022 06.
Article in En | MEDLINE | ID: mdl-35024889
ABSTRACT

BACKGROUND:

A growing body of evidence highlights sex differences in the diagnostic accuracy of cardiovascular imaging modalities. Nonetheless, the role of sex hormones in modulating myocardial perfusion and coronary flow reserve (CFR) is currently unclear. The aim of our study was to assess the impact of female and male sex hormones on myocardial perfusion and CFR.

METHODS:

Rest and stress myocardial perfusion imaging (MPI) was conducted by small animal positron emission tomography (PET) with [18F]flurpiridaz in a total of 56 mice (7-8 months old) including gonadectomized (Gx) and sham-operated males and females, respectively. Myocardial [18F]flurpiridaz uptake (% injected dose per mL, % ID/mL) was used as a surrogate for myocardial perfusion at rest and following intravenous regadenoson injection, as previously reported. Apparent coronary flow reserve (CFRApp) was calculated as the ratio of stress and rest myocardial perfusion. Left ventricular (LV) morphology and function were assessed by cardiac magnetic resonance (CMR) imaging.

RESULTS:

Orchiectomy resulted in a significant decrease of resting myocardial perfusion (Gx vs. sham, 19.4 ± 1.0 vs. 22.2 ± 0.7 % ID/mL, p = 0.034), while myocardial perfusion at stress remained unchanged (Gx vs. sham, 27.5 ± 1.2 vs. 27.3 ± 1.2 % ID/mL, p = 0.896). Accordingly, CFRApp was substantially higher in orchiectomized males (Gx vs. sham, 1.43 ± 0.04 vs. 1.23 ± 0.05, p = 0.004), and low serum testosterone levels were linked to a blunted resting myocardial perfusion (r = 0.438, p = 0.020) as well as an enhanced CFRApp (r = -0.500, p = 0.007). In contrast, oophorectomy did not affect myocardial perfusion in females. Of note, orchiectomized males showed a reduced LV mass, stroke volume, and left ventricular ejection fraction (LVEF) on CMR, while no such effects were observed in oophorectomized females.

CONCLUSION:

Our experimental data in mice indicate that sex differences in myocardial perfusion are primarily driven by testosterone. Given the diagnostic importance of PET-MPI in clinical routine, further studies are warranted to determine whether testosterone levels affect the interpretation of myocardial perfusion findings in patients.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Myocardial Perfusion Imaging Limits: Animals / Female / Humans / Male Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Myocardial Perfusion Imaging Limits: Animals / Female / Humans / Male Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2022 Document type: Article Affiliation country: